Are the ASPIRE Gene and anti-TFPI Therapies for Hemophilia Research awards renewable?

Are the ASPIRE Gene and anti-TFPI Therapies for Hemophilia Research awards renewable?

No. Each ASPIRE Gene and anti-TFPI Therapies for Hemophilia Research award is a one-time, non-renewable research grant.top

How are the funds dispersed?

How are the funds dispersed?


Yearly grant monies will be distributed at up to 50% at the beginning of the award year and up to 50% upon a subsequent milestone such as submission of the yearly grant progress/final report.  top

What are indirect costs?

What are indirect costs?


Examples of indirect costs are additional study expenses such as costs for publication, IRB/IEC review fees, supplies, software license fees, and travel.  top

Does the funding include Institutional overhead costs and indirect costs?

Does the funding include Institutional overhead costs and indirect costs?


Yes, the funding award includes indirect costs, and institutional overhead costs. Final budgets of those studies awarded a grant will be reviewed for fair market value before the contracting process begins.  top

Is the funding a per-annum or per-study amount?

Is the funding a per-annum or per-study amount?


Yearly grant monies will be distributed on a per-annum basis.  top

Will I receive a copy of the Review Committee’s evaluation of my grant proposal?

Will I receive a copy of the Review Committee’s evaluation of my grant proposal?


A summary review of the independent expert review panel’s comments will be provided on request to unsuccessful applicants in order to assist them in further refining their grant proposals for possible future submissions.  top

Pages

Subscribe to ASPIRE - Advancing Science Through Pfizer Investigator Research Exchange Research Awards RSS